Form 4 for IPSC Century Therapeutics, Inc.
Accepted 2025-12-16 00:00:00 ET · period of report 2025-12-12 · accession 0002001162-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-16 | 2025-12-12 | IPSC | Pfeiffenberger Brent | Pres, CEO, Dir | P - Purchase | $0.58 | +52.0K | 3.32M | +2% | +$30.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-12 | P | A | 52,000 | $0.58 | 3,322,990 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.577 to $0.5838. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. |